{"issuance_frequency":"","notes_translated":{"fr":"Le but de ce document est d'assister les intervenants quant à l'interprétation de la législation et les exigences réglementaires concernant la distribution d'échantillons de médicaments sur ordonnance, de médicaments sans ordonnance et de produits de santé naturels.","en":"The purpose of this document is to assist stakeholders with the interpretation of legislation and regulatory requirements about distributing samples of prescription drugs, non-prescription drugs and natural health products."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"ef4255b2-8cd9-4688-8015-b6e00b322de3","metadata_created":"2021-09-09T13:01:20.327230","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-09-09T13:01:20.327238","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-09-09","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Document d'orientation","distribution de médicaments sous forme d'échantillons","distribution d'échantillons","médicaments sur ordonnance","médicaments sans ordonnance","produits de santé naturels","intervenants","interprétation des lois et règlements"],"en":["Guidance document","distribution of drugs as samples","distributing samples","prescription drugs","non-prescription drugs","natural health products","stakeholders","interpretation of legislation and regulatory"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Ligne directrice sur la distribution de médicaments sous forme d’échantillons - Sommaire","en":"Guidance Document on the Distribution of Drugs as Samples - Summary"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"ef4255b2-8cd9-4688-8015-b6e00b322de3","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"8bb23b36-4693-4e76-8e58-7c4e2137183c","related_relationship":"","name_translated":{"fr":"Ligne directrice sur la distribution de médicaments sous forme d’échantillons - Sommaire","en":"Guidance Document on the Distribution of Drugs as Samples - Summary"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance Document on the Distribution of Drugs as Samples - Summary","language":["en"],"created":"2021-09-09T13:01:20.369892","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/natural-non-prescription/legislation-guidelines/guidance-documents/distribution-drugs-samples-summary.html","last_modified":null,"position":0,"revision_id":"06090841-8af3-4882-b6b6-5997b7c60d35","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"ef4255b2-8cd9-4688-8015-b6e00b322de3","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"6fa99106-f7e0-4490-8d86-aefec13c7769","related_relationship":"","name_translated":{"fr":"Ligne directrice sur la distribution de médicaments sous forme d’échantillons - Sommaire","en":"Guidance Document on the Distribution of Drugs as Samples - Summary"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance Document on the Distribution of Drugs as Samples - Summary","language":["fr"],"created":"2021-09-09T13:01:20.369898","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/naturels-sans-ordonnance/legislation-lignes-directrices/documents-reference/distribution-medicaments-echantillons-sommaire.html","last_modified":null,"position":1,"revision_id":"06090841-8af3-4882-b6b6-5997b7c60d35","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2020-04-27 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"ef4255b2-8cd9-4688-8015-b6e00b322de3","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The purpose of this document is to assist stakeholders with the interpretation of legislation and regulatory requirements about distributing samples of prescription drugs, non-prescription drugs and natural health products.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Guidance Document on the Distribution of Drugs as Samples - Summary","revision_id":"06090841-8af3-4882-b6b6-5997b7c60d35"}